Pharma channel feed

EMA rec­om­mends re­vok­ing au­tho­riza­tion of No­var­tis' sick­le cell drug

Last year

Janssen re­ports de­cline in 2022 net prices as out-of-pock­et costs grow

Last year

Mir­ror­ing Sen­ate coun­ter­parts, House com­mit­tee ad­vances PBM re­forms

Last year

Gilead adds more pa­tient rep­re­sen­ta­tion in next phase of HIV med Bik­tarvy cam­paign

Last year
Marketing

Mer­ck­'s $10.8B Prometheus buy­out can pro­ceed af­ter an­titrust re­view

Last year
Deals

Bi­par­ti­san law­mak­ers pres­sure FDA on com­mon chemother­a­pies now in short­age

Last year
Manufacturing

Lil­ly gears up trio of PhI­II tri­als for its oral GLP-1 amid No­vo Nordisk, Pfiz­er com­pe­ti­tion

Last year
R&D

Mi­rati’s drug sitra­va­tinib flops PhI­II in com­bo with Op­di­vo for cer­tain lung can­cer

Last year
R&D

An­nex­on’s GA drug miss­es on pri­ma­ry goal but win on vi­su­al acu­ity will be fo­cus of planned late-stage tri­al

Last year
R&D

No­vo Nordisk makes the case it’s more than We­govy in new cor­po­rate ad cam­paign

Last year
Marketing

Dis­trict court hands Janssen a win in patent feud with Vi­a­tris

Last year
Law

Pur­due Phar­ma nabs court ap­proval for $397M sale of con­sumer health unit

Last year
Law

Vee­va adds gen­er­a­tive AI tool for phar­ma reps as it rolls out new soft­ware plat­form

Last year
AI
Marketing

CD­MO se­cures a $98M+ NIH con­tract for pro­duc­tion of pe­di­atric HIV-pre­ven­tion prod­ucts

Last year
Manufacturing

New Biden pro­pos­al would ex­pose the ac­tu­al cost of drugs cov­ered by Med­ic­aid

Last year

Am­gen, Janssen reach set­tle­ment on Ste­lara biosim­i­lar drug, al­low­ing for 2025 launch at lat­est

Last year
Law

Com­pa­nies ask FDA for reg­u­la­tion, im­prove­ment of da­ta col­lec­tion from dig­i­tal health de­vices

Last year
FDA+

FDA warns Sure-BioChem over qual­i­ty and da­ta is­sues

Last year
FDA+
Manufacturing

Wal­greens asks fed­er­al court to toss Hu­mana's $642M pay­out in drug pric­ing case

Last year
Law

House com­mit­tee takes on PBMs as bi­par­ti­san sup­port for wider re­forms grows

Last year

Mar­ket­ingRx roundup: Mod­er­na, Pfiz­er, J&J top phar­mas on in­no­va­tion list; Bris­tol My­ers taps IPG for me­dia

Last year
Marketing

Weight loss field ex­pands as Pfiz­er's oral GLP-1 gath­ers com­par­isons to Novo's We­govy in PhII da­ta

Last year
R&D

Who else want­ed to buy Iver­ic? Be­fore the $5.9B Astel­las deal, five bio­phar­ma com­pa­nies took a look

Last year
Deals

Roche scraps sec­ond mid-stage schiz­o­phre­nia tri­al in as many years

Last year
R&D
First page Previous page 120121122123124125126 Next page Last page
A service from the Financial Times